Yes, that does help, but the PR only says the first cohort is receiving the second cycle, but it's not clear whether it is double the first dose or continuation of the original. If the IRB and Safety Committee said yes to doubling, that would be saying a lot.
HeyGov, Can you ask Andrew what is meant by "Cycle One and Cycle Two"? If you go to the Clincial Trials site in my previous post it mentions the pharma testing at Day 1 of Cycle 1 and Day 15 of Cycle 2--I'm not sure what that means. Thanks. Lee
edit: I think you answered some of this while I was typing.